Tradestie Institutional Equity Comparison Engine

LQDA vs AVDL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AVDL Overall Edge

AVDL Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avadel Pharmaceuticals plc Ordinary Share (AVDL) driven by superior Valuation, Momentum & Technical, Options & Structure while LQDA counters with relative strength in Growth & Margin. Fundamentally, LQDA trades at 15.8x Forward P/E with 47.1% operating margin (+314.6% YoY revenue) versus AVDL at 28.8x Forward P/E and 2.5% operating margin (+54.9% YoY). In options structure, LQDA sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against AVDL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AVDL
LQDA 15.8x vs AVDL 28.8x Fwd P/E
Growth & Margin Winner LQDA
Op Margin 47.1% vs 2.5% ยท YoY +314.6% vs +54.9%
Momentum & Technical Winner AVDL
1Y +83.6% vs +138.1% ยท 52W Pos 45% vs 89%
Options & Structure Winner AVDL
BREAKDOWN (9th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
LQDA NASDAQ
Liquidia Corporation Common Stock
Pharmaceutical Preparations
$54.43
-3.88% 1D
Market Cap $5.1B
1M Return +37.14%
1Y Return +83.64%
Forward P/E 15.8x
Unified AI Score
26.6 / 100 SELL
Tech 50.0 Fund 34.0 Flow 69.0 Mom 40.0
AVDL NASDAQ
Avadel Pharmaceuticals plc Ordinary Share
Pharmaceutical Preparations
$21.64
+0.05% 1D
Market Cap $2.1B
1M Return +0.65%
1Y Return +138.06%
Forward P/E 28.8x
Unified AI Score
62.9 / 100 BUY
Tech 75.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LQDA +83.64% AVDL +138.06% Spread: +41.85 pp (LQDA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LQDA TTM Op. Margin: 47.1% AVDL TTM Op. Margin: 2.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LQDA vs AVDL. Trailing 12-month operating profitability (LQDA 47.1% vs AVDL 2.5%) and valuation multiples (LQDA 15.8x vs AVDL 28.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LQDA (5) vs AVDL (5)
Institutional Metric LQDA AVDL Criterion Row Winner
Market Capitalization Scale $5.1B $2.1B Larger Scale LQDA
Trailing P/E Ratio Valuation 18.2x 16.8x Lower Multiple AVDL
Forward P/E Ratio Valuation 15.8x 28.8x Lower Multiple LQDA
Revenue Growth (YoY) Growth +314.6% +54.9% Higher Growth LQDA
Operating Margin (TTM) Profitability 47.1% 2.5% Higher Margin LQDA
Net Profit Margin Profitability -15.2% -0.1% Higher Margin AVDL
Return on Equity (ROE) Capital Efficiency 131.8% -0.3% Higher ROE LQDA
52-Week Range Position Momentum 45% ($22โ€“$94) 89% ($6โ€“$24) Stronger Trend AVDL
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 76% Vol 0.14ฮฒ ยท 2% Vol Lower Realized Risk AVDL
Unified Institutional Score Composite Signal 26.6 / 100 (SELL) 62.9 / 100 (BUY) Higher Composite AVDL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LQDA vs AVDL Buy Guide
LQDA BREAKDOWN
85d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live LQDA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AVDL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live AVDL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LQDA nor AVDL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.